About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials | 4,766 Studies Recruiting

Clinical TrialsPancreatic Cancer

Pancreatic Cancer Clinical Trials

Browse 4,766 clinical trials for pancreatic cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1021-1040 of 4,766 trials

CompletedStudy of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic AdenocarcinomaThe purpose of this Phase 1b study is to investigate whether intravenous administration of REOLYSIN® in combination with chemotherapy and pembrolizumab is effective and safe in…NCT02620423·San Antonio, Texas CompletedA Study Comparing Restrictive and Liberal Fluid Therapy During Pancreatecoduodenectomy Surgeryancreaticoduodenectomy (also known as PD or the Whipple procedure) is a major surgery often done for conditions like pancreatic cancer.NCT07072897·Kathmandu, Bagmati UnknownClinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic CancerPancreatic carcinoma (PC) is the deadliest malignant tumors worldwide.NCT06231160

Related Searches

pancreas cancertrials

Data from ClinicalTrials.govTerms

WithdrawnPhase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid TumorsPrimary Objectives are to determine the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D) of ZN-c3 and ZN-c3 and bevacizumab or ZN-c3 and bevacizumab plus pembrolizumab…NCT05431582

CompletedA Single-Patient Study Using AGS 006Argos Therapeutics, Inc., (Argos) proposes to study AGS-006 in a subject with newly diagnosed resectable pancreatic cancer.NCT00664482·New York, New York

WithdrawnTotal Tumor Mapping (TTM) for Resectable Pancreatic CancerAt present there is no validated prognostic tool for patients with resectable pancreatic cancer (RPC) to determine how best to tailor individual therapy.NCT03718650·Tampa, Florida

CompletedTrial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic CancerThe primary objective of this study is to compare the overall survival of patients with stage IV pancreatic cancer treated with gemcitabine alone or gemcitabine with bavituximab.NCT01272791·Chandler, Arizona and 18 others

CompletedIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerRATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of tumor cells, either by killing the cells or…NCT00654160·Rochester, Minnesota

UnknownMETabolic PROFILE of Hepatocarcinoma and Pancreatic TumorsHepatic (hepatocellular carcinoma (HCC)) and pancreatic (pancreatic adenocarcinoma (ADKP); pancreatic neuroendocrine tumors (TNEP)) primary tumors are the most common malignant…NCT05794048·Clichy

RecruitingA Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid TumorsThis study is an open, multicenter, dose-escalation and expansion-enrollment nonrandomized phase I clinical study to evaluate the safety, tolerability, pharmacokinetic…NCT06500052·Guangzhou, Guangdong

UnknownEpigenomic and Machine Learning Models to Predict Pancreatic CancerThe goal of the multicentric and interdisciplinary IMAGene project is to pursue early diagnosis for Pancreatic Cancers in high-risk asymptomatic subject groups, by developing and…NCT06334458·Toulouse and 3 others

RecruitingIncremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for SurgeryThe aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic…NCT05428358·Aalborg and 2 others

CompletedRadiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic CancerRetrospectively analyzed radiomics features of pancreatic ductal adenocarcinoma to predict staging and prognosisNCT04954378

CompletedTrial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.The purpose of this study is to evaluate if the combination of nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with GVAX is safe in patients with locally advanced…NCT03767582·Baltimore, Maryland

RecruitingProspective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk IndividualsThe purpose of this research is to see if adding blood-based tests and symptom review to standard-of-care pancreatic cancer screening procedures can identify cancer early among…NCT06122896·Boston, Massachusetts and 1 other

CompletedLaboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy ParticipantsRATIONALE: Studying samples of blood and tissue in the laboratory from patients with cancer and from healthy participants may help doctors learn more about cancer.NCT00899496·Winston-Salem, North Carolina

CompletedMesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsBackground: LMB-100 is a man-made protein designed to kill cancer cells. LMB-100 targets a cancer marker called mesothelin.NCT02810418·Bethesda, Maryland

UnknownAssessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancySarcopenia is defined as reduction in muscle mass and function according to the criteria of the European Working Group on Sarcopenia in older people.NCT05154474·Le Mans and 1 other

AvailableExpanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology, Inc., provides immunomodulatory AVM0703 to solid tumor and blood cancer patients upon request by a US licensed MD or DO.NCT05974410

UnknownImmunotherapy Study of Evofosfamide in Combination With IpilimumabAn immunotherapy study combining ipilimumab and evofosfamide for the treatment of patients with confirmed metastatic or locally advanced prostate cancer, metastatic pancreatic…NCT03098160·Houston, Texas

PreviousPage 52 of 239Next